10.5 Prostate, Bladder and Testicular Cancer
Key Takeaways
Use the Irish prostate referral pathway. A suspicious rectal examination takes priority over a reassuring PSA.
Refer recurrent or unexplained visible haematuria for urological assessment. Cystoscopy, imaging and tissue sampling have distinct roles.
A solid intratesticular lesion needs prompt assessment even with normal tumour markers.
Investigate possible prostate cancer in primary care
Take a urinary and general history, including voiding symptoms, infection, unexplained weight loss or bone pain. Ask about relevant family history, previous PSA results, prostate procedures and medicines such as finasteride. Lower urinary tract symptoms also occur with benign enlargement, infection and other conditions. Discuss the benefits and harms of testing before prostate assessment. A raised prostate-specific antigen (PSA) can occur with benign enlargement or inflammation. A result below the age-related referral threshold cannot overrule a suspicious digital rectal examination (DRE).
| Finding after assessment | Ireland NCCP GP pathway |
|---|---|
| Suspicious DRE in a symptomatic man | Refer regardless of PSA. For those aged up to and including 70, refer to a Rapid Access Prostate Clinic. The symptomatic pathway directs patients over 70 to urgent urology. |
| Raised age-related PSA with a non-suspicious DRE during routine lower urinary tract symptom (LUTS) evaluation | Address transient causes such as infection. When indicated, repeat raised PSA in the same laboratory after 6–12 weeks. Persistent elevation directs the same age-specific referrals. |
| Asymptomatic person asking for a PSA test | Use shared decision-making. Discuss family history and other risk, fitness and life expectancy, as well as the possibility of false reassurance, overdiagnosis and treatment effects. |
In the NCCP symptomatic chart, the raised thresholds by age are at least 2 µg/L under 50, 3 at 50–59, 4 at 60–69 and 5 from age 70. One µg/L equals one ng/mL. These are pathway thresholds. Diagnosis requires specialist assessment. If there are symptoms suspicious for advanced disease, such as new bone pain at rest or unexplained weight loss, the NCCP uses a separate pathway. An elevated age-related PSA or suspicious DRE in that setting triggers direct referral. A patient with back pain and new leg weakness, sensory change or bladder dysfunction needs emergency assessment for spinal cord or cauda equina compression.
At secondary care, the Irish NCCP guideline uses multiparametric MRI of the prostate before a first biopsy where appropriate. MRI helps decide whether and where to biopsy. The decision after a low-suspicion MRI considers residual clinical risk and patient preference, with planned PSA follow-up when biopsy is omitted. Histology, stage and risk guide management. Structured active surveillance is an option in low-risk localised disease. Discuss surgery or radiotherapy where indicated, and consider urinary, sexual and bowel effects. In advanced disease, systemic treatment commonly includes androgen deprivation with additional therapy if suitable.
NCCP GP referral guideline · NCCP diagnosis and staging · EAU treatment guidance · NICE spinal metastases and cord compression.
A 63-year-old man with months of worsening urinary hesitancy has no evidence of urinary infection. His PSA is 3.2 µg/L but DRE identifies a new hard, irregular nodule. Which next step follows the Irish NCCP symptomatic referral pathway?
Review in two years because PSA is below 4 µg/L
Refer to a Rapid Access Prostate Clinic for the suspicious DRE
Begin prostate cancer treatment in primary care without further assessment
Order prostate MRI in primary care and refer only if it is abnormal
Investigate persistent visible blood and stage a bladder lesion
Return to the symptom trajectory after a treated UTI. Visible blood that persists or recurs can indicate bladder or upper urinary tract disease even if the infection was real. Ask about smoking, occupational exposure and urinary irritative symptoms and assess for non-malignant causes. Use the local Irish urology referral pathway. Anticoagulation can increase bleeding. The cause of unexplained visible blood still needs investigation. Acute clot retention or haemodynamic compromise needs immediate care.
Cystoscopy examines the bladder directly. Upper-tract imaging with ultrasound and/or CT urography answers a separate question and is selected by risk, renal function and the clinical context. Normal ultrasound does not exclude a bladder lesion, and urine cytology is a selected adjunct, especially for high-grade disease. When a bladder tumour is found, transurethral resection provides tissue for type, grade and depth. Adequate sampling of detrusor muscle matters for staging when invasion is possible. Risk-based further treatment for non-muscle-invasive disease can include intravesical chemotherapy or BCG and scheduled cystoscopic follow-up. Localised muscle-invasive disease calls for multidisciplinary assessment for radical cystectomy or, in suitable patients, bladder-preserving trimodality treatment. Visible haematuria alone cannot distinguish these stages.
Urology model of care for Ireland · St James’s urology service · NICE suspected cancer guideline · EAU non-muscle-invasive diagnosis · EAU non-muscle-invasive treatment · EAU cystoscopic follow-up · EAU localised muscle-invasive treatment.
A 67-year-old former smoker has a second episode of painless visible haematuria after successful treatment of a culture-confirmed UTI. The repeat culture is negative and there is no clot retention or circulatory compromise. What is the most appropriate next step?
Repeat oral antibiotics without assessing other causes
Attribute the bleeding to the resolved infection and discharge from follow-up
Use a negative urine cytology test to cancel further evaluation
Arrange prompt urology assessment for cystoscopy and appropriate urinary tract imaging
Assess a persistent testicular lump
A firm, painless intratesticular mass or a persistent change in testicular size or texture warrants prompt ultrasound and urological assessment. Examine both testes and distinguish a lesion in the testis from a separate epididymal or scrotal finding. Ask about prior undescended testis, previous tumours and family history. Pain can occur with cancer. Sudden severe pain with possible torsion takes the emergency surgical pathway.
EAU guidance uses bilateral testicular ultrasound and measurement of AFP, hCG and LDH before and after orchidectomy. Normal markers do not rule out a germ cell tumour. A significant AFP elevation suggests a non-seminomatous component even when tumour morphology appears seminomatous. Radical inguinal orchidectomy is the usual diagnostic and initial treatment for a suspicious germ cell tumour. Avoid routine transscrotal biopsy. Discuss fertility preservation and an optional prosthesis as appropriate. The specialist stages confirmed disease and discusses surveillance, adjuvant treatment or systemic therapy based on histology, stage and risk. An individual follow-up plan can include markers and imaging.
EAU testicular cancer assessment · EAU testicular cancer treatment · St James’s urology service.
A 29-year-old notices a firm, painless testicular lump. Ultrasound shows a solid intratesticular lesion. AFP, hCG and LDH are within the laboratory reference ranges. Which plan is most appropriate?
Arrange prompt urological assessment for suspected germ cell tumour and discuss the inguinal approach if orchidectomy is indicated
Reassure because all three tumour markers are normal
Perform transscrotal needle biopsy as the routine first step
Treat as epididymitis and arrange review only if the mass becomes painful
Sections you finish are checked off in the contents.